Thomas Appio insider trades

Open-market stock purchases and sales by Thomas Appio, Chief Executive Officer at Bausch Health Companies Inc, from SEC Form 4 filings since Jan 6, 2017.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -72%.

Recent trades

DateStockTradeValue
Mar 2, 2026BHC Bausch Health Companies IncSold (not open market)$498K
Mar 2, 2026BHC Bausch Health Companies IncSold (not open market)$6.8M
Feb 27, 2026BHC Bausch Health Companies IncSold (not open market)$493K
Feb 26, 2026BHC Bausch Health Companies IncSold (not open market)$704K
Feb 25, 2026BHC Bausch Health Companies IncBought (not open market)—
Feb 9, 2026BHC Bausch Health Companies IncBought (not open market)—

Companies traded

  • BHC Bausch Health Companies Inc: 1 buy, last Mar 2, 2026
  • VRX Valeant Pharmaceuticals International, Inc: other filings, last Mar 7, 2018

Get free alerts when Thomas Appio files a new trade →